BRIC Self-Monitoring Blood Glucose Device Market to Reach USD 4 Bn in 2020, Says Renub Research in Its Topical Reports Available at MarketPublishers.c
10 Nov 2016 • by Natalie Aster
LONDON – In the past year, Russia, Brazil, China and India together have approximately 200 million people suffering from diabetes. At present, Russia accounts for the biggest share of the blood glucose lancet and blood glucose test strips market in the BRIC countries. Meantime, China holds the major share of the BRIC blood glucose meter market.
The self-monitoring blood glucose devices (SMBG) market in the BRIC countries is keeping to an upward trend, enjoying stable growth. Key market growth drivers include favourable government programs, enhancing diabetes care awareness, rising per capita healthcare expenditures worldwide and also increasing expenditures on diabetes management. In the upcoming years, the BRIC SMBG market will likely continue witnessing sustainable increase, and by late 2020 the market value is anticipated to touch USD 5 billion.
Renub Research topical report “BRIC Self-Monitoring Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast” offers a granular analysis of the self-monitoring blood glucose device (SMBG) market in the BRIC countries, discusses the market dynamics and also identifies top development trends. It uncovers updated statistics, contains detailed analyses of the four key countries in the region, identifies the key market growth opportunities and challenges, reviews the competitive pressures and also profiles top companies. The research publication comprises valuable forecasts for the BRIC SMBG market up to 2020.
Many other topical research publications prepared by Renub Research are available in this Market Publishers’ catalogue.